CT-FFR, which recently got a boost from the 2021 AHA/ACC chest pain guidelines, could play a key role for clinicians hoping to screen TAVR patients for coronary heart disease. 

“Our results are relevant to clinical practice, supporting the use of the Mediterranean diet in secondary prevention," researchers wrote. 

“Improving ancillary shielding barriers is paramount,” according to the authors of a brand new analysis. 

The median time from heart valve implantation to balloon dilatation was 4.6 months.

The trial is expected to enroll up to 650 patients from as many as 100 different facilities throughout the world.

Moderna cited “an ongoing internal investigation into certain matters” in its announcement.

The new equipment, which initially will be used to treat prostate and neuroendocrine tumors, is expected to be operational in July.

Computer scientists, rheumatologists and immunologists have pooled skill sets to develop a neural network that can distinguish between rheumatoid and psoriatic arthritis while also recognizing healthy joints with no arthritis at all.